Nick Colangelo has become senior vice president of corporate development and operations at Oscient Pharmaceuticals, the Waltham, Mass.-based company said yesterday. He comes to Oscient from Eli Lilly, where he was a managing director of Lilly Ventures.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The Atlantic reports that genetic counselors are coping with an influx of patients seeking advice on their direct-to-consumer genetic test results.

A small study finds differences between three genomic prostate cancer tests, Medscape reports.

In Nature this week: shared genetic architecture for asthma and allergic diseases, and more.

A survey of Canadians finds them to be divided on genetically modified food, the Ottawa Citizen reports.